Al-Sukhun Jehad, Törnwall Jyrki, Lindqvist Christian, Kontio Risto
Department of Oral and Maxillofacial Surgery, Helsinki University Central Hospital, Helsinki, Finland.
J Oral Maxillofac Surg. 2006 Jan;64(1):47-55. doi: 10.1016/j.joms.2005.09.013.
The purpose of this study was to share our clinical experience on the use of bioresorbable poly-L/DL-lactide implants (P[L/DL]LA) 70/30 (PolyMax; Synthes, Oberdorf, Switzerland) to repair, large (> or =2 cm2), inferior orbital wall defects and to evaluate whether P(L/DL)LA 70/30 implants adequately support the orbital soft tissue contents.
Thirteen patients who suffered orbital blowout fractures, with > or =2 cm2 bony defects in the inferior orbital wall, took part in the study. The inferior orbital wall was explored via subconjunctival approach. After repositioning of orbital content, each inferior orbital wall was reconstructed using a round plate of P(L/DL)LA 70/30. Computed tomography and magnetic resonance imaging coronal sections were undertaken before the operation and 2 and 36 weeks postoperatively.
The magnetic resonance imaging studies showed no abnormal tissue foreign body reactions in the orbital region. The material showed adequate strength to stabilize bone segments during the critical period of bone healing. The bone healing seems to take place along the bone fragments. The clinical outcome was excellent in 11 of the 13 cases (85%). At the end of the study, only one patient had mild enophthalmos.
Bioresorbable P(L/DL)LA 70/30 implants are safe and reliable for the repair of large defects (> or =2 cm2) in the inferior orbital wall. It seems that this is the first reported biodegradable material, in the literature, to promote bone healing along the bone fragments of the inferior orbital wall.
本研究旨在分享我们使用生物可吸收聚-L/DL-丙交酯植入物(P[L/DL]LA)70/30(PolyMax;Synthes,瑞士奥伯多夫)修复大面积(≥2 cm²)眶下壁缺损的临床经验,并评估P(L/DL)LA 70/30植入物是否能充分支撑眶内软组织。
13例眶底爆裂性骨折且眶下壁骨缺损≥2 cm²的患者参与了本研究。经结膜下入路探查眶下壁。眶内容物复位后,使用P(L/DL)LA 70/30圆形板重建每个眶下壁。在术前、术后2周和36周进行计算机断层扫描和磁共振成像冠状面扫描。
磁共振成像研究显示眶区无异常组织异物反应。该材料在骨愈合关键期显示出足够的强度来稳定骨段。骨愈合似乎沿着骨碎片发生。13例患者中有11例(85%)临床效果极佳。研究结束时,只有1例患者有轻度眼球内陷。
生物可吸收P(L/DL)LA 70/30植入物用于修复眶下壁大面积(≥2 cm²)缺损安全可靠。这似乎是文献中首次报道的可促进眶下壁骨碎片骨愈合的可生物降解材料。